Clinical Trials Logo

Otitis clinical trials

View clinical trials related to Otitis.

Filter by:

NCT ID: NCT01071902 Terminated - Acute Otitis Media Clinical Trials

Safety and Efficacy of Moxidex Otic

Start date: February 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if Moxidex otic solution is safe and effective in treating middle ear infections in patients with ear tubes.

NCT ID: NCT00945802 Terminated - Clinical trials for Acute Otitis Externa

FST-201 In The Treatment of Acute Otitis Externa

Start date: July 31, 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the efficacy of FST-201 compared to Ciprodex in the treatment of acute otitis externa. This trial is designed to enable filing of a New Drug Application in support of FST-201 for the indication of acute otitis externa.

NCT ID: NCT00945646 Terminated - Clinical trials for Acute Fungal Otitis Externa

FST-201 In The Treatment of Acute Fungal Otitis Externa

Start date: July 31, 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the efficacy of FST-201 compared to vehicle in the treatment of acute fungal otitis externa. This trial is designed to enable filing of a New Drug Application in support of FST-201 for the indication of acute fungal otitis externa.

NCT ID: NCT00523120 Terminated - Otitis Externa Clinical Trials

Topical Voltaren in Otitis Externa

Start date: September 2008
Phase: Phase 2
Study type: Interventional

Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.

NCT ID: NCT00315003 Terminated - Clinical trials for Otitis Media, Suppurative

TELI COM - Telithromycin in Children With Otitis Media

Start date: January 2006
Phase: Phase 3
Study type: Interventional

This is a multinational, randomized (1:1), double-blind, double-dummy, comparative, 2- treatmentgroup study in children (age range: ≥6 months and <72 months [< 6 years of age]) with AOM.Subjects will be randomized to receive either telithromycin (50 mg/mL) oral suspension 25 mg/kgonce daily for 5 days or azithromycin (40 mg/mL) oral suspension (10 mg/kg once on Day 1, followed by 5 mg/kg once daily on Days 2-5, not to exceed 500 mg onDay 1 and 250 mg/day from Days 2 - 5. Matching placebo suspensions for telithromycin and azithromycin will also be dispensed to provide blinding for the different treatment regimens.Assessments and reporting of safety will be carried out at all visits.

NCT ID: NCT00174811 Terminated - Otitis Media Clinical Trials

Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections

Start date: June 2005
Phase: Phase 3
Study type: Interventional

The clinical activity of telithromycin vs. cefuroxime in children with acute infections of the middle ear, ages 6 months to 59 months old will be studied.

NCT ID: NCT00016497 Terminated - Clinical trials for Otitis Media With Effusion

Adenoidectomy for Otitis Media in 2-3 Year Old Children

Start date: February 1997
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of three different surgical treatments (1. Bilateral myringotomy and tube insertion (M&T); 2. Adenoidectomy and bilateral myringotomy (A&T); 3. Adenoidectomy with myringotomy and tympanostomy tube insertion (A-M&T)) in reducing subsequent episodes of middle ear disease and hearing loss caused by the fluid in the middle ear in children aged 24-47 months. The fluid in the middle ear is of at least three months' duration and unresponsive to standardized, recent antimicrobial treatment. The children are assigned to one of the three surgical treatments. After surgery, they are followed with examinations monthly and at the time of intercurrent infections for three years.